Filing Details
- Accession Number:
- 0001213900-24-044877
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-17 21:00:14
- Reporting Period:
- 2024-05-15
- Accepted Time:
- 2024-05-17 21:00:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1769804 | Augmedix Inc. | AUGX | Services-Business Services, Nec (7389) | 833299164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1826616 | Emmanuel Krakaris | C/O Augmedix, Inc. 111 Sutter Street, Suite 1300 San Francisco CA 94104 | President, Ceo, And Secretary | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-15 | 9,375 | $0.00 | 62,426 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-15 | 3,528 | $1.19 | 58,898 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2024-05-15 | 9,375 | $0.00 | 9,375 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 140,625 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
- The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- Represents an original award of 150,000 RSUs to acquire shares of the Company's common stock. The RSU was granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. One-sixteenth (1/16th) of the RSU will vest quarterly in equal increments over four (4) years commencing on 02/15/2024, with the first one-sixteenth (1/16th) vesting on 5/15/2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Billionaire Hedge Funds
